These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24957554)

  • 41. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
    Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel.
    Rucinski A; Brons S; Richter D; Habl G; Debus J; Bert C; Haberer T; Jäkel O
    Radiat Oncol; 2015 Feb; 10():56. PubMed ID: 25886457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of rectum and bladder dose accumulation from external beam radiotherapy and brachytherapy for cervical cancer using two different deformable image registration techniques.
    Kadoya N; Miyasaka Y; Yamamoto T; Kuroda Y; Ito K; Chiba M; Nakajima Y; Takahashi N; Kubozono M; Umezawa R; Dobashi S; Takeda K; Jingu K
    J Radiat Res; 2017 Sep; 58(5):720-728. PubMed ID: 28595311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A multiple-image-based method to evaluate the performance of deformable image registration in the pelvis.
    Saleh Z; Thor M; Apte AP; Sharp G; Tang X; Veeraraghavan H; Muren L; Deasy J
    Phys Med Biol; 2016 Aug; 61(16):6172-80. PubMed ID: 27469495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose accumulation of multiple high dose rate prostate brachytherapy treatments in two commercially available image registration systems.
    Poder J; Yuen J; Howie A; Bece A; Bucci J
    Phys Med; 2017 Nov; 43():43-48. PubMed ID: 29195561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients.
    Wortel RC; Incrocci L; Pos FJ; Lebesque JV; Witte MG; van der Heide UA; van Herk M; Heemsbergen WD
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):737-44. PubMed ID: 25752386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
    Thörnqvist S; Muren LP; Bentzen L; Hysing LB; Høyer M; Grau C; Petersen JB
    Acta Oncol; 2013 Apr; 52(3):521-7. PubMed ID: 23409771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
    Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. End-to-end empirical validation of dose accumulation in MRI-guided adaptive radiotherapy for prostate cancer using an anthropomorphic deformable pelvis phantom.
    Bohoudi O; Lagerwaard FJ; Bruynzeel AME; Niebuhr NI; Johnen W; Senan S; Slotman BJ; Pfaffenberger A; Palacios MA
    Radiother Oncol; 2019 Dec; 141():200-207. PubMed ID: 31585817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multimodal image registration for the identification of dominant intraprostatic lesion in high-precision radiotherapy treatments.
    Ciardo D; Jereczek-Fossa BA; Petralia G; Timon G; Zerini D; Cambria R; Rondi E; Cattani F; Bazani A; Ricotti R; Garioni M; Maestri D; Marvaso G; Romanelli P; Riboldi M; Baroni G; Orecchia R
    Br J Radiol; 2017 Nov; 90(1079):20170021. PubMed ID: 28830203
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT.
    Chen L; Price RA; Wang L; Li J; Qin L; McNeeley S; Ma CM; Freedman GM; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):636-47. PubMed ID: 15380601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A dosimetric analysis comparing treatment of low-risk prostate cancer with TomoTherapy versus static field intensity modulated radiation therapy.
    Shah AP; Chen SS; Strauss JB; Kirk MC; Coleman JL; Coon AB; Miller C; Dickler A
    Am J Clin Oncol; 2009 Oct; 32(5):460-6. PubMed ID: 19564784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of three different adaptive strategies in image-guided radiotherapy of bladder cancer.
    Vestergaard A; Søndergaard J; Petersen JB; Høyer M; Muren LP
    Acta Oncol; 2010 Oct; 49(7):1069-76. PubMed ID: 20831498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biological optimization in volumetric modulated arc radiotherapy for prostate carcinoma.
    Mihaylov IB; Fatyga M; Bzdusek K; Gardner K; Moros EG
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1292-8. PubMed ID: 21570214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon.
    Elsayed H; Bölling T; Moustakis C; Müller SB; Schüller P; Ernst I; Willich N; Könemann S
    Strahlenther Onkol; 2007 Nov; 183(11):617-24. PubMed ID: 17960337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Position verification for the prostate: effect on rectal wall dose.
    Haverkort MA; van de Kamer JB; Pieters BR; van Tienhoven G; Assendelft E; Lensing AL; van Herk M; de Reijke TM; Stoker J; Koning CC
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):462-8. PubMed ID: 20646865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study of robustness of IMPT and IMRT for prostate cancer against organ movement.
    Soukup M; Söhn M; Yan D; Liang J; Alber M
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):941-9. PubMed ID: 19801105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterizing interfraction variations and their dosimetric effects in prostate cancer radiotherapy.
    Peng C; Ahunbay E; Chen G; Anderson S; Lawton C; Li XA
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):909-14. PubMed ID: 20732764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
    Cotter SE; Herrup DA; Friedmann A; Macdonald SM; Pieretti RV; Robinson G; Adams J; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1367-73. PubMed ID: 20934266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.